The Ottawa Hospital Research Institute is presently recruiting early-stage breast cancer patients in a new trial evaluating concurrent vs. sequential endocrine therapy in conjunction with post-operative radiation therapy. Outcomes of the phase 4 trial are endocrine toxicity, radiotherapy toxicity, rates of starting endocrine therapy and compliance, and cost-effectiveness ratios.
Click here for more information regarding this trial.
No comments:
Post a Comment